Diagnosis and treatment of therapy-related acute myeloid leukemia.
Strickland SA, Vey N.
Crit Rev Oncol Hematol. 2022 Mar;171:103607. doi: 10.1016/j.critrevonc.2022.103607. Epub 2022 Jan 31.
Therapy-related myeloid neoplasms.
Ganser A, Heuser M.
Curr Opin Hematol. 2017 Mar;24(2):152-158. doi: 10.1097/MOH.0000000000000316.
Therapy-Related Myeloid Neoplasms.
Bueso-Ramos CE, Kanagal-Shamanna R, Routbort MJ, Hanson CA.
Am J Clin Pathol. 2015 Aug;144(2):207-18. doi: 10.1309/AJCPU1JO2LYTWUAV.
Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
Yun J, Song H, Kim SM, Kim S, Kwon SR, Lee YE, Jeong D, Park JH, Kwon S, Yun H, Lee DS.
Hum Genomics. 2023 Feb 23;17(1):13. doi: 10.1186/s40246-023-00458-8.
Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapy.
Lee JW, Oh H, You JY, Lee ES, Lee JH, Song SE, Lee NK, Jung SP, An JS, Cho KR, Kim CY, Park KH.
Eur J Cancer. 2023 Sep;191:112952. doi: 10.1016/j.ejca.2023.112952. Epub 2023 Jun 22.
Therapy-related myeloid neoplasms.
Larson RA.
Haematologica. 2009 Apr;94(4):454-9. doi: 10.3324/haematol.2008.005157.
Therapy-related myeloid leukemia.
Godley LA, Larson RA.
Semin Oncol. 2008 Aug;35(4):418-29. doi: 10.1053/j.seminoncol.2008.04.012.
Therapy-related myeloid neoplasms.
Leone G, Fianchi L, Voso MT.
Curr Opin Oncol. 2011 Nov;23(6):672-80. doi: 10.1097/CCO.0b013e32834bcc2a.
Lessons learned from therapy-related acute myeloid leukemia.
Kayser S.
Haematologica. 2023 Apr 1;108(4):956-957. doi: 10.3324/haematol.2022.281742.
Therapy-related Myeloid Neoplasms Following PARP Inhibitors-Response.
Marmouset V, Morice PM, Pagès A, Leary A, Micol JB.
Clin Cancer Res. 2023 Mar 14;29(6):1158-1159. doi: 10.1158/1078-0432.CCR-23-0164.
